Clinical trial focus Private clinical trial site with over two decades of Phase 1-3 experience offers a turnkey partner for pharma companies conducting early to late stage trials, enabling faster recruitment and potentially shorter study timelines.

Therapeutic breadth Experience spanning schizophrenia, bipolar disorder, major depression, addiction, PTSD, tardive dyskinesia, diabetes and hypertension suggests versatility across CNS and metabolic indications, presenting cross‑sell opportunities to multiple R&D portfolios.

Smaller partner advantage Small to mid‑size employee base (11-50) indicates agile operations, personalized site management, and potential for stronger sponsor communication and study oversight compared to larger sites.

Financial scale Revenue in the 25 to 50 million range signals a growing clinical operations partner with budget authority for expanded trials, investigator meetings, and potential co‑development or long‑term contracting opportunities.

Regional positioning Chicagoland location positions Uptown Research Institute as a strong regional hub for U.S. trials, enabling targeted outreach to sponsors seeking diverse patient recruitment and rapid enrollment in Midwest cohorts.